November 9, 2026
Breaking
Technology

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

admin1 min read
Getting your Trinity Audio player ready...

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

The post Enveda secures $311M to bring more nature-derived AI drugs into clinical trials appeared first on TechCrunch.

Leave a Comment

Your email address will not be published. Required fields are marked *